1. PD1 + CD4 + T cells promote receptor editing and suppress autoreactivity of CD19 + CD21 low B cells within the lower respiratory airways in adenovirus pneumonia.
- Author
-
Lu B, Zhang Y, Wang J, Yang D, Liu M, Ma L, Yi W, Liang Y, Xu Y, Fan H, Liu W, Tang J, Zeng S, Cai L, Zhang L, Nie J, Zhang F, Gu X, Rosa Duque JS, Lu G, and Zhang Y
- Subjects
- Humans, Child, Preschool, Adenoviruses, Human immunology, Adenovirus Infections, Human immunology, Adenovirus Infections, Human metabolism, Male, Female, CD4-Positive T-Lymphocytes immunology, Autoimmunity, Autoantibodies immunology, Bronchoalveolar Lavage Fluid immunology, Child, Infant, Programmed Cell Death 1 Receptor metabolism, B-Lymphocytes immunology, B-Lymphocytes metabolism, Receptors, Complement 3d metabolism, Antigens, CD19 metabolism, Antigens, CD19 immunology
- Abstract
Human adenovirus (HAdV) pneumonia poses a major health burden for young children, however, factors that contribute to disease severity remain elusive. We analyzed immune cells from bronchoalveolar lavage (BAL) of children with HAdV pneumonia and found that CD19
+ CD21low B cells were significantly enriched in the BAL and were associated with increased autoantibody concentrations and disease severity. Myeloid cells, PD-1+ CD4+ T helper cells and CD21low B cells formed tertiary lymphoid structures within the respiratory tracts. Myeloid cells promoted autoantibody production by expressing high amounts of B cell activating factor (BAFF). In contrast, PD-1+ CD4+ T helper cells induced production of IgG1 and IgG3 antibodies but suppressed autoreactive IgGs by initiating B cell receptor editing. In summary, this study reveals cellular components involved in protective versus autoreactive immune pathways in the respiratory tract, and these findings provide potential therapeutic targets for severe HAdV lower respiratory tract infections., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF